Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
CRDF
$0.88
-2.19%
CRDF · Cardiff Oncology, Inc.
$0.88
-0.02 (-2.19%)
At close · Aug 18
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$71.36M
Shares
77.80M
All earnings calls
Earnings call · FY2025 Q2
Cardiff Oncology, Inc. Q2 FY2025 Earnings Call
Cardiff Oncology, Inc. Q2 FY2025 Earnings Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$121,000
-25.8% YoY
Diluted EPS
-$0.21
Net income
-$13.94M
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
41 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Jul 29, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 29, 2025 · complete as-filed document